3151 - 3175 of 6462 Results
Title
Year
-
OPENTitle: The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 9Issue #: 3Start Page: 553End Page: 563Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191648Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191648?id=journal-of-parkinsons-disease%2Fjpd191648Citation Count: 44
-
OPENTitle: Ten Years of the International Parkinson Disease Genomics Consortium: Progress and Next StepsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 10Issue #: 1Start Page: 19End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191854Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191854?id=journal-of-parkinsons-disease%2Fjpd191854Citation Count: 33
-
OPENTitle: Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson’s Disease in the Harvard Biomarkers StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 505End Page: 510Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-191882Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7416447Citation Count: 43
-
OPENTitle: Clinical Progression of Parkinson’s Disease: Insights from the NINDS Common Data ElementsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1075End Page: 1085Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-201932Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8177750Citation Count: 31
-
OPENTitle: A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson’s Disease: Study Protocol and DesignJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1195End Page: 1207Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202019Best OA location URL: https://escholarship.org/uc/item/9nz468vjCitation Count: 13
-
OPENTitle: The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging OpportunitiesJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 351End Page: 354Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202038Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202038?id=journal-of-parkinsons-disease%2Fjpd202038Citation Count: 312
-
OPENTitle: Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on BiomarkersJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 69Issue #: 1Start Page: 263End Page: 276Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-190069Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6513710Citation Count: 25
-
OPENTitle: Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1Journal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 3Start Page: 581End Page: 594Publication Date:Open Access(OA) Status: OPENLicense: unspecified-oaDOI - Digital Object Identifier: 10.3233/jpd-150570Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150570?id=journal-of-parkinsons-disease%2Fjpd150570Citation Count: 30
-
OPENTitle: Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 4Start Page: 783End Page: 792Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-150682Best OA location URL: http://doi.org/10.3233/JPD-150682Citation Count: 46
- Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study Protocol2016OPENTitle: Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study ProtocolJournal Name: JMIR Research ProtocolsPublisher: JMIR Publications Inc.Vol: 5Issue #: 3Start Page: e172End Page: e172Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/resprot.5990Best OA location URL: https://www.researchprotocols.org/2016/3/e172/PDFCitation Count: 73
-
OPENTitle: Parkinson’S Disease is Ready for Precision MedicineJournal Name: Personalized MedicinePublisher: Informa UK LimitedVol: 13Issue #: 5Start Page: 405End Page: 407Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/pme-2016-0052Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/pme-2016-0052Citation Count: 7
-
OPENTitle: An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 CohortsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 623End Page: 629Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191786Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191786?id=journal-of-parkinsons-disease%2Fjpd191786Citation Count: 49
-
OPENTitle: Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 TrialsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1663End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212672Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212672?id=journal-of-parkinsons-disease%2Fjpd212672Citation Count: 42
-
OPENTitle: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 557End Page: 570Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212714Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212714?id=journal-of-parkinsons-disease%2Fjpd212714Citation Count: 61
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 89
-
OPENTitle: Network structure of brain atrophy in de novo Parkinson's diseaseJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 4Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.08440Best OA location URL: https://doi.org/10.7554/elife.08440Citation Count: 260
-
OPENTitle: Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.58997Best OA location URL: https://doi.org/10.7554/elife.58997Citation Count: 59
-
OPENTitle: Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementiaJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 52End Page: 52Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-017-0276-4Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-017-0276-4Citation Count: 143
-
OPENTitle: The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole PolinskiJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 16Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.050605Best OA location URL: https://journals.biologists.com/dmm/article-pdf/16/12/dmm050605/3311458/dmm050605.pdfCitation Count: 0
- Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)2023OPENTitle: Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)Journal Name: IBRO Neuroscience ReportsPublisher: Elsevier BVVol: 15Issue #:Start Page: 320End Page: 326Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ibneur.2023.10.001Best OA location URL: http://www.ibroneuroreports.org/article/S2667242123022716/pdfCitation Count: 0
-
OPENTitle: GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body DisordersJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 6Start Page: 1065End Page: 1070Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29773Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29773Citation Count: 4
-
OPENTitle: Structural changes in early-stage Parkinson’s disease with resting tremor at node, edge and network levelJournal Name: Brain Research BulletinPublisher: Elsevier BVVol: 220Issue #:Start Page: 111169End Page: 111169Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brainresbull.2024.111169Best OA location URL: https://doi.org/10.1016/j.brainresbull.2024.111169Citation Count: 1
-
OPENTitle: The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neuronsJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page: 88End Page: 88Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-024-00779-9Best OA location URL: https://link.springer.com/content/pdf/10.1186/s13024-024-00779-9.pdfCitation Count: 31
-
OPENTitle: Molecular Insight into Amyloid Fibril-Templated Aggregation of BiomarkersJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 16Issue #: 11Start Page: 2076End Page: 2084Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.5c00103Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.5c00103?ref=article_openPDFCitation Count: 1
- ePresentations2024OPENTitle: ePresentationsJournal Name: European Journal of NeurologyPublisher: WileyVol: 31Issue #: S1Start Page: e16338End Page: e16338Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ene.16338Best OA location URL: https://doi.org/10.1111/ene.16338Citation Count: 0